Press Releases Aelis Farma

Equities

AELIS

FR0014007ZB4

Market Closed - Euronext Paris Other stock markets 08:06:34 16/05/2024 BST			5-day change	1st Jan Change
13.1 ^EUR	0.00%		+0.77%	0.00%

04-18	Aelis Farma SA Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	CI
04-02	Aelis Farma SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aelis Farma : Availability of documents for the General meeting on June 4, 2024	05-14	PU
Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures	05-14	BU
Aelis Farma: Availability of the 2023 Universal Registration Document	04-25	BU
Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	04-18	BU
Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook	04-02	BU
Aelis Farma : Inside Information / Other news releases	05/07/23	PU
Aelis Farma announces its 2023 financial calendar	01/02/23	AQ
Aelis Farma announces positive results from its safety trials in healthy volunteers and the authorization to start the first trial in people with Down syndrome with AEF0217, its drug candidate for the treatment of cognitive disorders	16/11/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer